ctrl K

/

Search

Popular

KO Coca Cola Company Stock

TSLA Tesla Inc Stock

AMD Advanced Micro Devices Stock

SPY SPDR S&P 500 ETF Trust ETF

NVDA Nvidia Stock

Watchlist Price Alert

CEL-SCI Corporation (CVM)

AMEX: CVM · Real-Time Price · USD

2.49

-0.03 (-1.19%)

At close: Jul 03, 2025, 2:35 PM

Insider Trading

Transcripts

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

CVM News

16 days ago - FDA's Approval of Keytruda for PD-L1 Positive Head and Neck Cancer Patients Signals a Clear Pathway for CEL-SCI's Multikine to Address a Major Unmet Need in PD-L1 Negative Cancer Patients - businesswire.com
42 days ago - CEL-SCI Announces Closing of Public Offering - businesswire.com
44 days ago - CEL-SCI Announces Pricing of Public Offering - businesswire.com
44 days ago - CEL-SCI Announces Proposed Public Offering - businesswire.com
44 days ago - CEL-SCI's Multikine Investigational Cancer Medicine Potentially Available for Commercialization by Summer 2025 in Saudi Arabia - businesswire.com
46 days ago - CEL-SCI Announces Combination of Common Stock - businesswire.com
50 days ago - CEL-SCI Reports Fiscal Second Quarter 2025 Financial Results - businesswire.com
72 days ago - CEL-SCI to File for Regulatory Approval of Multikine in Saudi Arabia—Pursuing Local Partnerships for Commercialization and Manufacturing to Serve Middle East and North Africa Market - businesswire.com
87 days ago - New Study in the Scientific Journal “Cancer Cell” Supports CEL-SCI's Strategy to Seek Early Approval for Multikine in Head and Neck Cancer Based on Pre-Surgical Tumor Responses - businesswire.com

Add to Watchlist

✕

Sections

Stocks
IPOs
ETFs
Blog

Services

Pricing Plan
Discord Bot
Free Newsletter
Get Support

Website

Login
FAQ
Sitemap
Learning Center
Affiliate Program

Company

About
Contact Us
Terms of Use
Privacy Policy
Data Disclaimer
Imprint

© 2025 Stocknear. All rights reserved.